1.Clinical Analysis of Recurrent Chronic Subdural Hematoma.
Hyoung Lae KANG ; Hyung Shik SHIN ; Tae Hong KIM ; Yong Soon HWANG ; Sang Keun PARK
Journal of Korean Neurosurgical Society 2006;40(4):262-266
OBJECTIVE: Chronic subdural hematoma(CSDH) is usually treated by burr hole trephination and hematoma evacuation with closed drainage and the surgical result is relatively good in most reported series. But, some patients experience the recurrence of CSDH. We study the clinical factors related to the recurrence of CSDH. METHODS: 213 consecutive patients with CSDH who were treated with burr hole trephination and hematoma evacuation with closed drainage. The medical records, radiologic findings were reviewed retrospectively and clinical factors associated with the recurrent CSDH were analysed statistically. RESULTS: 8.4%(18 cases) of the 213 patients who were treated due to CSDH were recurred. The demographic variables such as age, sex, coexisting diseases were not related to the recurrence. The preoperative hematoma thickness and postoperative hematoma thickness were not associated with the recurrence. The only factor related to the recurrence is postoperative hematoma density in this study. CONCLUSION: This study shows that postoperative hematoma density was strongly related to the recurrence of CSDH. However, several factors associated with the recurrent CSDH were reported in the liletrature. Thus, further study will be needed to uncover the factors related to the recurrence of CSDH. Chronic subdural hematoma(CSDH);Recurrence;Postoperative hematoma density.
Drainage
;
Hematoma
;
Hematoma, Subdural, Chronic*
;
Humans
;
Medical Records
;
Recurrence
;
Retrospective Studies
;
Trephining
2.Association of Interleukin-12 Gene Polymorphism with Persistence of Hepatitis B Virus Infection and Hepatocellular Carcinoma.
Jin Sun PARK ; Jae Youn CHEONG ; Joon Koo KANG ; Jin Hee CHO ; Sukyong YU ; Hyoung Doo SHIN ; Byung Lae PARK ; Sung Won CHO
The Korean Journal of Gastroenterology 2007;50(5):313-318
BACKGROUND/AIMS: Infection with hepatitis B virus (HBV) may result in various conditions. Natural course of HBV infection is influenced by various host immune factors and cytokines play a crucial role in host immune defense. This study was undertaken to investigate the association between HBV persistence and development of hepatocelluar carcinoma (HCC) and single nucleotide polymorphisms (SNPs) of interleukin (IL)-12A. METHODS: Between March 2002 and December 2004, seven hundred thirty Korean patients with HBV infection and 320 healthy individuals who recovered from HBV infection were enrolled. We assessed polymorphisms and haplotype in IL-12A, and the genotype distributions of the HBV clearance and persistence groups were compared in order to investigate the association between HBV persistence and SNPs of IL-12A. Moreover, the genotypic distributions between patients with HCC and without HCC were compared to investigate the association between the development of HCC and SNPs of IL-12A. RESULTS: We asssesed the SNPs of IL-12A at position +6400, +6624 and +7003. On the basis of logistic regression analysis, no statistically significant association with HBV persistence was observed with IL-12A exon 7 +6400, +6624, 3' UTR +7003 SNP and haplotype of IL-12A +6400/+6624/+7003. Furthermore, no statistically significant association of HCC development with IL-12A exon 7 +6400, +6624, 3' UTR +7003 SNP and haplotype of IL-12A +6400/+6624/+7003 was observed. CONCLUSIONS: These results suggest that SNPs and haplotype of IL-12A are not associated with HBV persistence and development of HCC. Further studies are needed to identify the host genetic factors in immune defense including cytokine gene polymorphisms of both IL-12A and IL-12B.
Adult
;
Aged
;
Carcinoma, Hepatocellular/etiology/*genetics/virology
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Haplotypes
;
Hepatitis B/complications/*genetics
;
Hepatitis B virus/isolation & purification
;
Hepatitis B, Chronic/complications/*genetics
;
Heterozygote
;
Humans
;
Interleukin-12 Subunit p35/*genetics
;
Liver Neoplasms/etiology/*genetics/virology
;
Male
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Retrospective Studies
;
Risk Factors
3.Cerebral Bypass Surgery for Treating Unclippable and Uncoilable Aneurysms.
Jung Soo KIM ; Sang Hyuk PARK ; Chang Ki HONG ; Jun Suk HUH ; Hyoung Lae KANG ; Jin Yang JOO
Korean Journal of Cerebrovascular Surgery 2011;13(3):194-200
OBJECTIVE: Fusiform and dissecting aneurysms cannot be treated with conventional clipping or coiling surgery. Various methods are used for treating these aneurysms, including proximal occlusion of the parent artery or trapping the aneurysms with or without cerebral revascularization. We report here on our experience with treating unclippable and uncoilable aneurysms and we present the clinical and angiographic outcomes. METHODS: Nine patients with unclippable and uncoilable aneurysms were managed during a 5 year period at our institution. We retrospectively reviewed all the patients with aneurysms and who underwent multimodal techniques. The mean age of the 9 patients was 56.5 years. The mean clinical follow-up period was 28.1 months. Six patients presented with subarachnoid hemorrhage and 2 had diplopia. Of these patients, 3 had aneurysms arising from the posterior inferior cerebellar artery (PICA), 2 had vertebral artery (VA) aneurysms, 2 had internal carotid artery aneurysms and 2 had middle cerebral artery aneurysms. Eight aneurysms were fusiform and 1 was a giant saccular aneurysm. RESULTS: The treatment included surgical trapping with bypass in 4 patients, endovascular trapping with bypass in 4 patients and vein graft bypass in 1 patient. Among the bypass surgeries, high-flow bypass was performed for a giant internal cerebral artery (ICA) aneurysm. Trapping of the aneurysms with coil and occipital artery (OA)-PICA bypass were performed for 2 VA aneurysms of the PICA origin. There was no recurrent bleeding or ischemic symptoms during the follow-up periods. CONCLUSION: The cerebral bypass technique is a useful, safe for the treatment of dissecting and otherwise unclippable/uncoilable aneurysms.
Aneurysm
;
Aneurysm, Dissecting
;
Arteries
;
Carotid Artery, Internal
;
Cerebral Arteries
;
Cerebral Revascularization
;
Diplopia
;
Follow-Up Studies
;
Hemorrhage
;
Humans
;
Intracranial Aneurysm
;
Parents
;
Pica
;
Retrospective Studies
;
Subarachnoid Hemorrhage
;
Transplants
;
Veins
;
Vertebral Artery
4.Compliance with Atovaquone-Proguanil against Malaria of Korean Travelers Abroad.
Nak Hyun KWON ; Tae Soo PARK ; Hyo Sung KANG ; Sung Hoon KIM ; Lae Seok HWANG ; Hye Jin NOH ; Ji Hwan BANG ; Jae Yoon KIM ; Hyoung Shik SHIN
Infection and Chemotherapy 2008;40(5):255-258
BACKGROUND: Recently, many Korean people travel abroad where malaria is prevalent. However, in Korea, relatively little is known about compliance of chemoprophylaxis against malaria. This study was performed to determine the factors influencing compliance of chemoprophylaxis against malaria in Korean travelers. MATERIALS AND METHODS: Face to face interview, telephone interview and e-mail correspondence were performed to 241 people who were prescribed with atovaquone-proguanil at the international travelers' clinic of National Medical Center between February 2007 and October 2007. RESULTS: Total of 55 people out of 235 reported one or more events of adverse reactions after chemoprophylaxis (total 76 events). However, in 38 adverse events the link between chemoprophylaxis and adverse events were very weak. Compliance of malaria chemoprophylaxis with atovaquone-proguanil was 53.9% in the study group. The predictive factors for non-compliance were package tour, travel of business affair and young age group. Conclusions: Compliance of malaria chemoprophylaxis in Korea travelers was low compared with Dutch and French studies. More efforts to increase compliance are needed, especially in travelers on package tour, business travel and people under age 40.
Aluminum Hydroxide
;
Atovaquone
;
Carbonates
;
Chemoprevention
;
Commerce
;
Compliance
;
Drug Combinations
;
Electronic Mail
;
Humans
;
Interviews as Topic
;
Korea
;
Malaria
;
Proguanil
5.Compliance with Atovaquone-Proguanil against Malaria of Korean Travelers Abroad.
Nak Hyun KWON ; Tae Soo PARK ; Hyo Sung KANG ; Sung Hoon KIM ; Lae Seok HWANG ; Hye Jin NOH ; Ji Hwan BANG ; Jae Yoon KIM ; Hyoung Shik SHIN
Infection and Chemotherapy 2008;40(5):255-258
BACKGROUND: Recently, many Korean people travel abroad where malaria is prevalent. However, in Korea, relatively little is known about compliance of chemoprophylaxis against malaria. This study was performed to determine the factors influencing compliance of chemoprophylaxis against malaria in Korean travelers. MATERIALS AND METHODS: Face to face interview, telephone interview and e-mail correspondence were performed to 241 people who were prescribed with atovaquone-proguanil at the international travelers' clinic of National Medical Center between February 2007 and October 2007. RESULTS: Total of 55 people out of 235 reported one or more events of adverse reactions after chemoprophylaxis (total 76 events). However, in 38 adverse events the link between chemoprophylaxis and adverse events were very weak. Compliance of malaria chemoprophylaxis with atovaquone-proguanil was 53.9% in the study group. The predictive factors for non-compliance were package tour, travel of business affair and young age group. Conclusions: Compliance of malaria chemoprophylaxis in Korea travelers was low compared with Dutch and French studies. More efforts to increase compliance are needed, especially in travelers on package tour, business travel and people under age 40.
Aluminum Hydroxide
;
Atovaquone
;
Carbonates
;
Chemoprevention
;
Commerce
;
Compliance
;
Drug Combinations
;
Electronic Mail
;
Humans
;
Interviews as Topic
;
Korea
;
Malaria
;
Proguanil
6.A Case of Washed Platelet Transfusion in a Patient with History of Recurrent Transfusion Reaction.
Ji Yeon SOHN ; Joo Hyoung HWANG ; Hyang Lae LEE ; Hye Lim YI ; Su Jin KANG ; Hyeon Seok EOM ; Eun Kyung LEE ; Sinyoung KIM ; Kyoung Un PARK ; Sun Young KONG
Korean Journal of Blood Transfusion 2015;26(3):316-322
Anaphylactic transfusion reaction is caused by deficiency of certain protein(s) in the recipient. We report on the experience of platelet count recovery using washed platelets for transfusion in a patient who developed an anaphylactic transfusion reaction. A 50-year old male diagnosed with angioimmunoblastic T-cell lymphoma was treated with chemotherapy followed by autologous hematopoietic stem cell transplantation. Immediately after starting transfusion of apheresis platelets, he began sweating and complained of visual impairment, chest discomfort, and abdominal pain. Both systolic and diastolic blood pressures and oxygen saturation monitored by pulse oximetry were decreased. Platelet transfusion was discontinued immediately and hydrocortisone was administered, and the symptoms and signs were resolved within two hours. Laboratory test using post-transfusion blood showed no apparent evidence of hemolysis. Platelet washing procedure using normal saline three times was newly set to prevent anaphylactic reaction in the patient. Transfusions of washed platelets were performed 20 times for 60 days, and the patient showed no anaphylactic reaction during this period. He showed no evidence of immunoglobulin A, haptoglobin, C3, or C4 deficiencies. We confirmed that washed platelet transfusion is highly effective for prevention of anaphylactic transfusion reaction.
Abdominal Pain
;
Anaphylaxis
;
Blood Component Removal
;
Blood Group Incompatibility*
;
Blood Platelets*
;
Drug Therapy
;
Haptoglobins
;
Hematopoietic Stem Cell Transplantation
;
Hemolysis
;
Humans
;
Hydrocortisone
;
Immunoglobulin A
;
Lymphoma, T-Cell
;
Male
;
Oximetry
;
Oxygen
;
Platelet Count
;
Platelet Transfusion*
;
Sweat
;
Sweating
;
Thorax
;
Vision Disorders
7.Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
Se Hoon LEE ; Boram LEE ; Joon Ho SHIM ; Kwang Woo LEE ; Jae Won YUN ; Sook Young KIM ; Tae You KIM ; Yeul Hong KIM ; Young Hyeh KO ; Hyun Cheol CHUNG ; Chang Sik YU ; Jeeyun LEE ; Sun Young RHA ; Tae Won KIM ; Kyung Hae JUNG ; Seock Ah IM ; Hyeong Gon MOON ; Sukki CHO ; Jin Hyoung KANG ; Jihun KIM ; Sang Kyum KIM ; Han Suk RYU ; Sang Yun HA ; Jong Il KIM ; Yeun Jun CHUNG ; Cheolmin KIM ; Hyung Lae KIM ; Woong Yang PARK ; Dong Young NOH ; Keunchil PARK
Cancer Research and Treatment 2019;51(1):211-222
PURPOSE: With the emergence of next-generation sequencing (NGS) technology, profiling a wide range of genomic alterations has become a possibility resulting in improved implementation of targeted cancer therapy. In Asian populations, the prevalence and spectrum of clinically actionable genetic alterations has not yet been determined because of a lack of studies examining high-throughput cancer genomic data. MATERIALS AND METHODS: To address this issue, 1,071 tumor samples were collected from five major cancer institutes in Korea and analyzed using targeted NGS at a centralized laboratory. Samples were either fresh frozen or formalin-fixed, paraffin embedded (FFPE) and the quality and yield of extracted genomic DNA was assessed. In order to estimate the effect of sample condition on the quality of sequencing results, tissue preparation method, specimen type (resected or biopsied) and tissue storage time were compared. RESULTS: We detected 7,360 non-synonymous point mutations, 1,164 small insertions and deletions, 3,173 copy number alterations, and 462 structural variants. Fifty-four percent of tumors had one or more clinically relevant genetic mutation. The distribution of actionable variants was variable among different genes. Fresh frozen tissues, surgically resected specimens, and recently obtained specimens generated superior sequencing results over FFPE tissues, biopsied specimens, and tissues with long storage duration. CONCLUSION: In order to overcome, challenges involved in bringing NGS testing into routine clinical use, a centralized laboratory model was designed that could improve the NGS workflows, provide appropriate turnaround times and control costs with goal of enabling precision medicine.
Academies and Institutes
;
Asian Continental Ancestry Group
;
DNA
;
Humans
;
Korea
;
Methods
;
Paraffin
;
Point Mutation
;
Precision Medicine
;
Prevalence